Blueberries Medical (OTC: BBRRF) Raises C$1 Million Through Private Placement
When news emerges about raising fresh capital, it almost always leads to considerable focus on a company, and this morning it could be Blueberries Medical (OTC: BBRRF) in light of the announcement it made last Friday. The company was in sharp focus after it announced the details about a non-brokered C$1 million private placement.
Key Announcement
The cannabis company, which is a licensed producer in Latin America, announced a non-brokered private placement comprising 96064935 common shares for the price of C$0.011 each to raise total gross proceeds of C$1.05 million. In the news release, the company also revealed that the proceeds from the private placement would be used for financing and also expanding its operations. Additionally, the fund would also be used for working capital and general corporate purposes. The offering would be closed on March 25, 2024.
Further Details
The company also announced that the offering would be led by Terraflos Inc., which is a cannabis company in its own right and based out of Latin America. Blueberries Medical has become a major name in the high-end cannabis space, and its operations are presently located in Bogota Savannah of Central Columbia.
Technicals
| +/- EMA(20) | 0.0086 (+16.28%) |
| +/- SMA(50) | 0.0091 (+9.89%) |
| +/- SMA(200) | 0.0115 (-13.04%) |
| 5-Day Perf. | +47.06% |
| 1-Month Perf. | +5.26% |
| 3-Month Perf. | +8.7% |
| 6-Month Perf. | -11.5% |
| YTD Perf. | +1.01% |
| 1-Year Perf. | -24.24% |
| RSI(14) | 54.55 |
| ATR(14) | – |
| ADX(14) | 9.44 |
| Beta (5Y) | 0.70 |
